Fol. Biol. 2017, 63, 155-163

https://doi.org/10.14712/fb2017063040155

Oridonin Induces Apoptosis in Human Nasopharyngeal Carcinoma Cells Involving ROS Generation

P. Zhang, Su-Rong Zhao, F. Liu, X.-J. Sun, Hao Liu

School of Pharmacy and Anhui Engineering Technology Research Centre of Biochemical Pharmaceuticals, Bengbu Medical College, Bengbu, Anhui, PR China

Received June 2017
Accepted August 2017

References

1. Bai, L., Wang, S. (2014) Targeting apoptosis pathways for new cancer therapeutics. Annu. Rev. Med. 65, 139-155. <https://doi.org/10.1146/annurev-med-010713-141310>
2. Bodmer, J. L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J., Tschopp, J. (2000) TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat. Cell Biol. 2, 241-243. <https://doi.org/10.1038/35008667>
3. Bodur, C., Karakas, B., Timucin, A. C., Tezil, T., Basaga, H. (2016) AMP-activated protein kinase couples 3-bromopyruvate- induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins. Mol. Carcinog. 55, 1584-1597. <https://doi.org/10.1002/mc.22411>
4. Clutton, S. (1997) The importance of oxidative stress in apoptosis. Br. Med. Bull. 53, 662-668. <https://doi.org/10.1093/oxfordjournals.bmb.a011637>
5. Czabotar, P. E., Lessene, G., Strasser, A., Adams, J. M. (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 15, 49-63. <https://doi.org/10.1038/nrm3722>
6. Dean, E., Greystoke, A., Ranson, M., Dive, C. (2012) Biomarkers of cell death applicable to early clinical trials. Exp. Cell Res. 318, 1252-1259. <https://doi.org/10.1016/j.yexcr.2012.03.020>
7. Fang, Z., Jiang, C., Feng, Y., Chen, R., Lin, X., Zhang, Z., Han, L., Chen, X., Li, H., Guo, Y., Jiang, W. (2016) Effects of G6PD activity inhibition on the viability, ROS generation and mechanical properties of cervical cancer cells. Biochim. Biophys. Acta 1863, 2245-2254. <https://doi.org/10.1016/j.bbamcr.2016.05.016>
8. Hacker, G., Paschen, S. A. (2007) Therapeutic targets in the mitochondrial apoptotic pathway. Expert Opin. Ther. Targets 11, 515-526. <https://doi.org/10.1517/14728222.11.4.515>
9. Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature 407, 770-776. <https://doi.org/10.1038/35037710>
10. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90. <https://doi.org/10.3322/caac.20107>
11. Jolly, P. D., Tisdall, D. J., De’ath, G., Heath, D. A., Lun, S., Hudson, N. L., McNatty, K. P. (1997) Granulosa cell apoptosis, aromatase activity, cyclic adenosine 3’,5’-monophosphate response to gonadotropins, and follicular fluid steroid levels during spontaneous and induced follicular atresia in ewes. Biol. Reprod. 56, 830-836. <https://doi.org/10.1095/biolreprod56.4.830>
12. Kakkar, P., Singh, B. K. (2007) Mitochondria: a hub of redox activities and cellular distress control. Mol. Cell. Biochem. 305, 235-253. <https://doi.org/10.1007/s11010-007-9520-8>
13. Kingston, D. G. (2011) Modern natural products drug discovery and its relevance to biodiversity conservation. J. Nat. Prod. 74, 496-511. <https://doi.org/10.1021/np100550t>
14. Li, C. Y., Wang, E. Q., Cheng, Y., Bao, J. K. (2011) Oridonin: an active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics. Int. J. Biochem. Cell Biol. 43, 701-704. <https://doi.org/10.1016/j.biocel.2011.01.020>
15. Li, D., Han, T., Liao, J., Hu, X., Xu, S., Tian, K., Gu, X., Cheng, K., Li, Z., Hua, H., Xu, J. (2016) Oridonin, a promising ent-kaurane diterpenoid lead compound. Int. J. Mol. Sci. 17, pii: E1395. <https://doi.org/10.3390/ijms17091395>
16. Li, Y., Wang, Y., Wang, S., Gao, Y., Zhang, X., Lu, C. (2015) Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells. Med. Oncol. 32, 365. <https://doi.org/10.1007/s12032-014-0365-1>
17. Lin, C. J., Ho, H. Y., Cheng, M. L., You, T. H., Yu, J. S., Chiu, D. T. (2010) Impaired dephosphorylation renders G6PDknockdown HepG2 cells more susceptible to H2O2-induced apoptosis. Free Radic. Biol. Med. 49, 361-373. <https://doi.org/10.1016/j.freeradbiomed.2010.04.019>
18. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., Wang, X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157. <https://doi.org/10.1016/S0092-8674(00)80085-9>
19. Liu, Z., Ouyang, L., Peng, H., Zhang, W. Z. (2012) Oridonin: targeting programmed cell death pathways as an anti-tumour agent. Cell Prolif. 45, 499-507. <https://doi.org/10.1111/j.1365-2184.2012.00849.x>
20. Martinou, J. C., Youle, R. J. (2011) Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev. Cell 21, 92-101. <https://doi.org/10.1016/j.devcel.2011.06.017>
21. Mates, J. M., Segura, J. A., Alonso, F. J., Marquez, J. (2012) Oxidative stress in apoptosis and cancer: an update. Arch. Toxicol. 86, 1649-1665. <https://doi.org/10.1007/s00204-012-0906-3>
22. Mondal, S., Bandyopadhyay, S., Ghosh, M. K., Mukhopadhyay, S., Roy, S., Mandal, C. (2012) Natural products: promising resources for cancer drug discovery. Anticancer Agents Med. Chem. 12, 49-75. <https://doi.org/10.2174/187152012798764697>
23. Nathan, C. (2003) Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J. Clin. Invest. 111, 769-778. <https://doi.org/10.1172/JCI200318174>
24. Newman, D. J., Cragg, G. M. (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311-335. <https://doi.org/10.1021/np200906s>
25. Ohta, S. (2003) A multi-functional organelle mitochondrion is involved in cell death, proliferation and disease. Curr. Med. Chem. 10, 2485-2494. <https://doi.org/10.2174/0929867033456440>
26. Ola, M. S., Nawaz, M., Ahsan, H. (2011) Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol. Cell. Biochem. 351, 41-58. <https://doi.org/10.1007/s11010-010-0709-x>
27. Qi, X., Zhang, D., Xu, X., Feng, F., Ren, G., Chu, Q., Zhang, Q., Tian, K. (2012) Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line. Int. J. Nanomedicine 7, 1793-1804.
28. Scatena, R., Bottoni, P., Botta, G., Martorana, G. E., Giardina, B. (2007) The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am. J. Physiol. Cell Physiol. 293, C12-21. <https://doi.org/10.1152/ajpcell.00314.2006>
29. Shi, M., Lu, X. J., Zhang, J., Diao, H., Li, G., Xu, L., Wang, T., Wei, J., Meng, W., Ma, J. L., Yu, H., Wang, Y. G. (2016) Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53- and caspase-3-mediated mechanisms. Oncotarget 7, 22623-22631. <https://doi.org/10.18632/oncotarget.8033>
30. Trachootham, D., Lu, W., Ogasawara, M. A., Nilsa, R. D., Huang, P. (2008) Redox regulation of cell survival. Antioxid. Redox Signal. 10, 1343-1374. <https://doi.org/10.1089/ars.2007.1957>
31. Volkmann, N., Marassi, F. M., Newmeyer, D. D., Hanein, D. (2014) The rheostat in the membrane: BCL-2 family proteins and apoptosis. Cell Death Differ. 21, 206-215. <https://doi.org/10.1038/cdd.2013.153>
32. Wang, S., Zhong, Z., Wan, J., Tan, W., Wu, G., Chen, M., Wang, Y. (2013) Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells. Am. J. Chin. Med. 41, 177-196. <https://doi.org/10.1142/S0192415X13500134>
33. Xu, Z. Z., Fu, W. B., Jin, Z., Guo, P., Wang, W. F., Li, J. M. (2016) Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma. Leuk. Lymphoma 57, 888-898. <https://doi.org/10.3109/10428194.2015.1061127>
34. Zhang, L., Wang, K., Lei, Y., Li, Q., Nice, E. C., Huang, C. (2015) Redox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response. Free Radic. Biol. Med. 89, 452-465. <https://doi.org/10.1016/j.freeradbiomed.2015.08.030>
35. Zhao, Z., Chen, Y. (2014) Oridonin, a promising antitumor natural product in the chemotherapy of hematological malignancies. Curr. Pharm. Biotechnol. 15, 1083-1092. <https://doi.org/10.2174/1389201015666141111115608>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Archive